SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 37 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,719 | +42875.0% | 6,368 | -3.7% | 0.00% | – |
| Q1 2023 | $4 | -42.9% | 6,614 | -35.6% | 0.00% | – |
| Q4 2022 | $7 | -100.0% | 10,274 | -2.7% | 0.00% | – |
| Q3 2022 | $24,000 | +118.2% | 10,561 | +368.5% | 0.00% | – |
| Q1 2022 | $11,000 | -8.3% | 2,254 | +68.5% | 0.00% | – |
| Q4 2021 | $12,000 | +50.0% | 1,338 | +142.8% | 0.00% | – |
| Q3 2021 | $8,000 | -96.5% | 551 | -96.5% | 0.00% | -100.0% |
| Q2 2021 | $228,000 | +714.3% | 15,827 | +686.6% | 0.01% | – |
| Q1 2021 | $28,000 | +115.4% | 2,012 | +365.7% | 0.00% | – |
| Q4 2020 | $13,000 | – | 432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |